# NOV Inc. (NOV)

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-28  
**Report type:** Primer (steps 1–3 of 19)  
**API endpoint:** GET /api/v1/research/NOV/primer

## Business Model

---
step: 01
title: Business Overview
ticker: NOV
source: coverage-next-full
created: 2026-05-28
---

### Step 01 — Business Overview: NOV Inc. (NYSE: NOV)

#### Key Findings

- NOV is the world's largest OEM of land and offshore drilling rig systems, controlling >50% market share of the global installed drillship, semi-submersible, and land-rig population. This installed-base advantage creates a durable captive aftermarket.
- The January 2024 reorganization into two segments — **Energy Products and Services (EPS)** and **Energy Equipment (EE)** — simplifies the reporting narrative but also clarifies the split between activity-sensitive (EPS) and long-cycle backlog-driven (EE) revenue.
- The business has undergone a significant reset since the 2014–2020 oilfield-equipment depression: ~$10B in goodwill impairments written off, workforce restructured, balance sheet deleveraged, and capital allocation discipline imposed. The company emerging from that cycle is leaner and more focused than its predecessor.

#### Company Profile

| Field | Value |
|-------|-------|
| Ticker | NOV (NYSE) |
| Full Name | NOV Inc. (renamed from National Oilwell Varco, 2022) |
| CIK | 0001021860 |
| SIC | 3533 — Oil & Gas Field Machinery & Equipment |
| HQ | Houston, TX |
| Employees | ~28,000 |
| Founded | 1862 (modern form via 2005 merger of National Oilwell and Varco) |
| Fiscal Year | Calendar (December 31) |

#### Business Description

NOV designs, manufactures, and sells equipment, components, and consumables used in oil and gas drilling, completion, and production — and provides oilfield services — globally in more than 60 countries. It is the dominant OEM of drilling rig systems and subsea/FPSO capital equipment, and the primary supplier of consumable downhole tools, drill pipe, and wireline equipment to the broader oilfield services ecosystem.

The company operates at an intermediate step in the oilfield value chain: **downstream of E&P operators and drilling contractors** (who decide where and how much to drill), but **upstream of services firms** (who use NOV equipment in the field). This positioning insulates NOV somewhat from day-to-day service pricing pressure while exposing it to capital spending cycle volatility.

#### Two-Segment Structure (effective Q1 2024)

##### Energy Products and Services (EPS)

| Item | Detail |
|------|--------|
| Revenue (FY2025) | ~$3.9B (~44–45% of total) |
| Q4 2025 revenue | $989M |
| Q4 2025 op margin | 14.2% |
| Demand driver | Rig count, well count, drilling activity |

Products: drill pipe, downhole motors, drill-bit databases, wireline cables, intervention and coiled-tubing equipment, solids-control systems, field services.

Character: activity-sensitive. Revenue moves with global and US rig count. Margin sensitive to mix (US vs. international), tariff costs, and pricing power in competitive tool rental/service markets.

##### Energy Equipment (EE)

| Item | Detail |
|------|--------|
| Revenue (FY2025) | ~$4.8B (~55% of total) |
| Q4 2025 revenue | $1.33B |
| Q4 2025 op margin | 13.5% |
| Demand driver | FPS/FPSO FIDs, offshore rig orders, backlog conversion |
| FY2025 ending backlog | $4.34B |

Products: drilling rigs (land and offshore), blowout preventers (BOPs), FPSO and FLNG topside equipment, subsea production systems, marine cranes, offshore wind installation vessels.

Character: long-lead-time capital equipment with multi-quarter backlog. Revenue recognized on percentage-of-completion or delivery. FY2025 was the **fourth consecutive year of revenue growth and EBITDA margin expansion** in this segment.

#### Historical Context

NOV took cumulative goodwill impairments of ~$10B+ across 2015–2020, reflecting the depth of the oilfield-equipment depression. The 2019 net loss of $(6.1)B and the 2020 loss of $(2.5)B permanently reduced the balance-sheet goodwill from the 2005-era acquisition binge. Today's company carries ~$5B goodwill (down from ~$12B pre-bust), has no near-term refinancing risk ($1.55B cash vs. $2.34B total debt), and generates meaningful FCF ($876M FY2025).

#### CEO Transition

- **Clay Williams** retired Feb 28, 2026, after serving as Chairman & CEO since 2014.
- **Jose Bayardo** — previously President & COO (and before that CFO) — assumed Chairman, President & CEO effective January 1, 2026.
- Internal continuity; no strategic pivot expected.

#### Thesis Implications

NOV's investment story is a late-cycle equipment OEM with backlog visibility into the offshore FPS recovery (2026–2030) and a shareholder-return program funded by FCF. The key variable is whether the EPS margin compression (tariff + activity-driven) is cyclical and recoverable, or structural, which would impair normalized earnings power below current consensus estimates.

#### Assumption Register Updates

- A03 (from Step 00): Two-segment structure post-Q1 2024 reorg is durable — confirmed in 10-K and FY2025 investor communications.

#### Source Index

| ID | Source |
|----|--------|
| S1 | NOV_financials/xbrl/xbrl_summary.md |
| S3 | NOV_financials/other/stockanalysis_summary.md |
| S5 | NOV_financials/sec_filings/10K_FY2025_summary.md |
| S7 | NOV_financials/presentations/investor_presentation_2025.md |
| S8 | NOV_financials/proxy/governance_and_compensation.md |
| S9 | NOV_financials/industry/competitive_landscape.md |

## Financial Snapshot

---
step: 04
title: Financial Snapshot
ticker: NOV
source: coverage-next-full
created: 2026-05-28
---

### Step 04 — Financial Snapshot: NOV Inc.

#### Key Findings

- NOV's financial profile shows a company that **recovered strongly from the 2014–2020 depression** (EBITDA $172M in 2021 → $1,219M in 2024), but is now experiencing a **cycle-mix compression** in 2025–2026: gross margin peaked at 22.7% (FY2024), fell to 20.2% (FY2025) and 18.5% (Q1 2026).
- Free cash flow ($876M FY2025) remains robust and dramatically higher than reported GAAP net income ($145M), reflecting large D&A from goodwill amortization and working capital tailwinds. FCF quality is the core of the capital return story.
- The balance sheet is conservative: $1.55B cash, $2.34B total debt, $0.79B net debt against $6.32B equity. Leverage is not a risk; capital allocation optionality is the variable.

#### Income Statement Summary

##### Annual Trend (FY2021–FY2025, USD M)

| FY | Revenue | Gross Profit | Gross Margin | Op Income | Op Margin | Net Income | EPS (Dil) | Adj EBITDA |
|----|---------|-------------|-------------|-----------|-----------|------------|-----------|------------|
| 2021 | 5,524 | 774 | 14.0% | (134) | (2.4%) | (250) | (0.65) | 172 |
| 2022 | 7,237 | 1,334 | 18.4% | 264 | 3.7% | 155 | 0.39 | 565 |
| 2023 | 8,583 | 1,833 | 21.4% | 651 | 7.6% | 993 | 2.50 | 953 |
| 2024 | 8,870 | 2,010 | 22.7% | 876 | 9.9% | 635 | 1.60 | 1,219 |
| 2025 | 8,744 | 1,767 | 20.2% | 494 | 5.7% | 145 | 0.39 | 849 (1,030 mgmt adj) |

**Key observation**: Revenue plateaued in FY2024–FY2025 while margins compressed sharply. FY2025 vs FY2024: op margin –420bps, net income –77%, EPS –76%. This earnings compression is the primary reason for NOV's low reported P/E (trailing 82×) and the argument for "forward-looking" valuation using normalized or FY2027 consensus earnings.

##### Quarterly Trend (Q2 2024 – Q1 2026, USD M)

| Quarter | Revenue | Gross Profit | Gross Margin | Op Income | Op Margin | Net Income | EPS |
|---------|---------|-------------|-------------|-----------|-----------|------------|-----|
| Q2 2024 | 2,216 | 590 | 26.6% | 313 | 14.1% | 226 | 0.57 |
| Q3 2024 | 2,191 | 469 | 21.4% | 194 | 8.9% | 130 | 0.33 |
| Q4 2024 | 2,308 | 493 | 21.4% | 207 | 9.0% | 160 | 0.41 |
| Q1 2025 | 2,103 | 447 | 21.3% | 152 | 7.2% | 73 | 0.19 |
| Q2 2025 | 2,188 | 446 | 20.4% | 143 | 6.5% | 108 | 0.29 |
| Q3 2025 | 2,176 | 412 | 18.9% | 107 | 4.9% | 42 | 0.11 |
| Q4 2025 | 2,277 | 462 | 20.3% | 92 | 4.0% | (78) | (0.21) |
| Q1 2026 | 2,052 | 379 | 18.5% | 47 | 2.3% | 19 | 0.05 |

**Q1 2026 is the trough candidate**: 2.3% op margin with $47M op income on $2.05B revenue — the lowest in this cycle. This sets the comparison base for the recovery thesis.

#### Cash Flow Summary

##### Annual (FY2021–FY2025, USD M)

| FY | Op CF | CapEx | FCF | Buybacks | Dividends | Net Capital Return |
|----|-------|-------|-----|----------|-----------|-------------------|
| 2021 | 291 | (201) | 90 | 0 | (20) | 20 |
| 2022 | (179) | (214) | (393) | 0 | (78) | 78 |
| 2023 | 143 | (283) | (140) | 0 | (79) | 79 |
| 2024 | 1,304 | (351) | 953 | (229) | (108) | 337 |
| 2025 | 1,251 | (375) | 876 | (315) | (190) | 505 |

**FCF >> Net Income**: FY2025 FCF $876M vs. NI $145M — a 6× ratio. This gap reflects D&A running well above capex (indicating significant legacy goodwill and asset amortization) and working capital changes. FCF is the more reliable metric for dividend/buyback sustainability analysis.

**FY2026 FCF guide**: 40–50% of EBITDA (~$1.0B guided) = **$400–500M FCF**. At $190M dividends, residual for buyback = $210–310M. Buyback pace decelerates from $315M (FY2025).

#### Balance Sheet

##### Annual Snapshot (FY2021–FY2025, USD M)

| FY | Cash | Total Debt | LT Debt | Net Debt | Equity | Total Assets | WC |
|----|------|-----------|---------|---------|--------|-------------|-----|
| 2021 | 1,591 | 2,388 | 1,708 | 797 | 5,064 | 9,550 | 2,992 |
| 2022 | 1,069 | 2,366 | 1,717 | 1,297 | 5,134 | 10,135 | 3,056 |
| 2023 | 816 | 2,377 | 1,712 | 1,561 | 6,242 | 11,294 | 3,405 |
| 2024 | 1,230 | 2,386 | 1,703 | 1,156 | 6,428 | 11,361 | 3,423 |
| 2025 | 1,552 | 2,340 | 1,688 | 788 | 6,322 | 11,291 | 3,414 |

**Net debt of $0.79B** is the lightest it has been in this cycle. Leverage ratio: $0.79B net debt / $1.03B adj EBITDA = **0.77× net leverage** — extremely conservative. No near-term refinancing requirement; FY2025 debt reduction ~$46M (not aggressive paydown, rather steady maturity management).

#### Profitability & Margin Analysis

| Metric | FY2023 | FY2024 | FY2025 | Q1 2026 |
|--------|--------|--------|--------|---------|
| Gross Margin | 21.4% | 22.7% | 20.2% | 18.5% |
| Op Margin | 7.6% | 9.9% | 5.7% | 2.3% |
| Net Margin | 11.6% | 7.2% | 1.7% | 0.9% |
| FCF Margin | (1.6%) | 10.8% | 10.0% | n/a |
| Adj EBITDA Margin | 11.1% | 13.7% | 11.8% (9.7% GAAP) | ~7–8% |

**Margin recovery thesis**: If op margin reverts to FY2023 levels (7–8%) on flat revenue ($8.7B), that implies ~$600–700M operating income. At historical tax + minority interest levels, NI would be ~$400–500M, or ~$1.10–1.40/share on 360M diluted shares. Forward consensus of $1.30 FY2027E is consistent with this recovery path.

#### Valuation Snapshot

| Metric | Value |
|--------|-------|
| Price (retrieval) | $20.32 |
| Market Cap | $7.29B |
| Enterprise Value | $8.26B |
| EV/Adj EBITDA (FY2025) | 8.0× |
| EV/Adj EBITDA (FY2026E, ~$1.0B) | ~8.3× |
| P/E (trailing) | 82.1× (distorted by low NI) |
| P/E (FY2026E consensus $0.80) | 25.4× |
| P/E (FY2027E consensus $1.30) | 15.6× |
| FCF Yield (FY2025 FCF $876M / mkt cap $7.29B) | 12.0% |
| FCF Yield (FY2026E FCF ~$400–500M) | 5.5–6.9% |
| Dividend Yield | 1.77% ($0.50/share) |

**8–9× EV/EBITDA** on depressed margins is the base valuation anchor. Peers (SLB, HAL) trade 8–12× depending on quality and cycle position. At EV/EBITDA 9× on $1.1B normalized EBITDA (FY2023–FY2024 average), implied EV = $9.9B, equity = $9.1B, or ~$25/share — implying ~23% upside from current price.

#### Assumption Register Updates

- A06: FY2025 op margin compression cyclical + tariff, not structural — hypothesis; FY2026 H2 will test this (cost savings + offshore backlog mix).
- A08: Net debt $0.79B conservative — confirmed.
- A11: Normalized cycle-mid ROIC ~10–12% — consistent with FY2023–FY2024 op margins when extrapolated to invested capital base.

#### Source Index

| ID | Source |
|----|--------|
| S1 | NOV_financials/xbrl/xbrl_summary.md |
| S3 | NOV_financials/other/stockanalysis_summary.md |
| S5 | NOV_financials/sec_filings/10K_FY2025_summary.md |
| S6 | NOV_financials/other/consensus.md |
| S7 | NOV_financials/presentations/investor_presentation_2025.md |

## Recent Catalysts

---
step: 12
title: Catalysts, Bull Case & Bear Case
ticker: NOV
source: coverage-next-full
created: 2026-05-28
---

### Step 12 — Catalysts, Bull Case & Bear Case: NOV Inc.

#### Key Findings

- NOV is a catalyst-rich story: the FPSO FID pipeline, cost savings delivery, and margin recovery are all observable in the next 12–18 months. The stock is priced for a continuation of the trough (2.3% op margin), not for any recovery.
- At $20.32 and 8.3× forward EV/EBITDA on guided ~$1.0B EBITDA, NOV is not cheap on current-period metrics but is compelling on a recovery basis (EV/EBITDA 7–8× on $1.1B+ normalized EBITDA = $22–27 stock, +8–33% upside).
- The binary nature of the call: if margin recovery and FPSO FIDs materialize, the stock re-rates meaningfully. If tariff/cost headwinds persist and FIDs disappoint, FY2026 consensus needs another cut.

#### Positive Catalysts (12–24 Month)

| Catalyst | Likely Timing | Market Impact |
|----------|--------------|---------------|
| FPSO FID announcements (Brazil, West Africa, Norway) | Q2–Q4 2026 | New EE bookings; backlog replenishment signals → stock re-rates |
| Q2 2026 margins — first evidence of $100M cost savings | August 2026 | Positive: EPS op margin recovery from Q1 trough; potential earnings estimate upgrades |
| Tariff relief or cost pass-through success | H2 2026 | Reduction in EPS margin pressure; FY2026 EPS upside vs. $0.80 consensus |
| Backlog sustained or growing (Q2+ 2026 earnings) | Quarterly | Confidence in EE revenue visibility through 2027–2028 |
| Buyback continuation at $200M+ pace | Ongoing | Share count –2–3% per year; mechanical EPS uplift |
| Management FY2027 guidance issuance (Feb 2027) | Feb 2027 | First window for analysts to underwrite $1.30 consensus EPS FY2027 |
| Energy price stability ($70–80 Brent) | Ongoing | Sustains FPSO FID pace; reduces bear-case probability |

#### Negative Catalysts (12–24 Month)

| Catalyst | Likely Timing | Market Impact |
|----------|--------------|---------------|
| FY2026 guidance cut (revenue or EBITDA reduction) | Any quarter | Consensus estimates revised lower; stock de-rates |
| FPSO FID deferrals (announced by majors) | Any time | EE bookings disappoint; backlog depletion concerns; multiple compression |
| Tariff escalation (new Section 301, auto tariffs on equipment) | Policy-driven | Further EPS margin compression; FY2026 EPS below $0.80 |
| Oil price drop below $65/bbl sustained | Macro-driven | E&P capex cuts; US land rig count falls; EPS revenue erosion |
| Goodwill impairment charge | Possible FY2025 10-K or FY2026 | One-time NI hit; psychological negative; no FCF impact |
| Dividend cut (if FCF compresses below $300M) | FY2026 actuals | High impact signal; market would re-price significantly lower |

#### Valuation Scenarios

##### Base Case (~55% probability)

| Assumption | Value |
|-----------|-------|
| FY2026E revenue | $8.7B (in line with guidance) |
| FY2026E Adj EBITDA | $1.0B |
| FY2027E Adj EBITDA | $1.1B (moderate recovery) |
| EV / EBITDA (FY2027) | 9× (sector average) |
| Implied EV | $9.9B |
| Less net debt | $0.8B |
| Equity value | $9.1B |
| Per share (360M) | **$25** |
| Upside from $20.32 | **+23%** |
| Time horizon | 18 months |

##### Bull Case (~25% probability)

| Assumption | Value |
|-----------|-------|
| FY2027E Adj EBITDA | $1.3B (margin recovery to ~14%; strong FPSO bookings) |
| EV / EBITDA | 10× (re-rating on visible backlog) |
| Implied EV | $13.0B |
| Less net debt | $0.6B |
| Equity value | $12.4B |
| Per share | **$34** |
| Upside | **+67%** |

##### Bear Case (~20% probability)

| Assumption | Value |
|-----------|-------|
| FY2027E Adj EBITDA | $750M (no margin recovery; oil price softens) |
| EV / EBITDA | 7× (discount for no recovery) |
| Implied EV | $5.25B |
| Less net debt | $1.0B (FCF eroded) |
| Equity value | $4.25B |
| Per share | **$12** |
| Downside | **–41%** |

#### Asymmetry Assessment

- Expected value: (55% × $25) + (25% × $34) + (20% × $12) = $13.75 + $8.50 + $2.40 = **$24.65** vs. current $20.32
- Implied EV / current price: **+21%** probability-weighted
- Upside/downside ratio: +23% base / –41% bear = **0.56 R/R** — slightly below 1:1; requires high conviction on base/bull case to justify position

#### Thesis Pivot Points

The working thesis is confirmed if:
1. Q2/Q3 2026 EPS margins recover toward 8–10% (tariff cost mitigation working)
2. EE bookings ≥ $1.1B/quarter (FID pipeline converting)
3. FY2026 FCF maintains $400M+ (capital return sustainability intact)

The thesis is negated if:
1. FY2026 EBITDA guidance is cut below $850M
2. FPSO FIDs below 5/year in 2026
3. Brent oil price falls and sustains below $60/bbl

---

#### Bull Case

- **Offshore FPS upcycle delivers above expectations**: 10+ FPSO FIDs in 2026, average 9/year through 2030, drives EE bookings beyond current $4.34B backlog. Revenue mix tilts toward higher-margin subsea/FPSO equipment; EE op margins expand to 15–16%. Combined with the EPS margin recovery from $100M cost savings, total op margin recovers to 10–12% by FY2027, driving EPS to $1.50+, well above $1.30 consensus. Stock re-rates to 12× FY2027 EPS = $18+ vs. current $20, meaning the stock is already pricing in the bull case; however, on EV/EBITDA 10–11× on $1.3B EBITDA the implied equity is $34.
- **Capital return acceleration surprises the market**: FY2026 FCF comes in at $600M+ (cost savings + mix), allowing buyback continuation at $400M+/year. Share count falls below 340M by end of 2027, compounding per-share earnings beyond what top-line recovery alone implies. A $400M buyback at $20/share retires ~20M shares (~5.5%), which at FY2027E op margin recovery adds $0.20+ per share to EPS mechanically.
- **Valuation re-rating as a quality compounder**: If NOV demonstrates sustained FCF yield >10%, dividend growth, and declining share count through a downturn, institutional investors re-classify it from "cyclical OEM" to "FCF compounder with cyclical optionality" — commanding 12–14× forward P/E instead of 15×. At 12× FY2027E $1.50 EPS = **$18** (modest on P/E but EV/EBITDA gives more upside as above); the more powerful re-rating comes if consensus bridges to $2.00 EPS FY2028 on a full recovery.

#### Bear Case

- **Tariff headwinds become structural, not cyclical**: The EPS segment margins do not recover because the 2025 tariff regime becomes the permanent operating environment. Cost savings ($100M) are real but insufficient to offset $150M+ of ongoing tariff cost increases. EPS segment op margin stays at 6–8% (vs. 12–14% pre-2025), permanently reducing the company's blended EBITDA margin from a normalized 13–14% to 10–11%, cutting normalized EBITDA to $850–900M. At 7–8× EV/EBITDA, the stock is fairly priced or overvalued at $20.
- **FPSO FID cycle disappoints and backlog depletes**: Oil price softens to $60–65/bbl range (OPEC+ production hike, demand softness), causing Petrobras and West African operators to delay FPSO FIDs. Annual FID pace falls to 4–5/year vs. 8+ expected. EE bookings average $800M/quarter vs. $1.0B+ needed to sustain backlog. By end of FY2027, backlog depletes from $4.34B to <$3.0B; analysts model EE revenue declining in FY2028. Multiple de-rates to 7× on declining earnings visibility; stock falls to $12–14.
- **Dividend cut forces multiple reset**: If FCF compresses to $300M (soft EBITDA + working capital outflow from project delays), management cannot sustain the $190M dividend + meaningful buyback simultaneously. A dividend cut from $0.50 to $0.25/share would represent a significant negative signal — income-oriented institutional holders (who bought on the 1.77% yield) sell. Stock falls to $13–15 (10× FY2026E $1.30 GAAP op + multiple discount for dividend risk).

---

#### Assumption Register Updates

- A14: Bull case requires backlog conversion + margin recovery + sustained capital return — confirmed and quantified.
- A15: Bear case requires cycle rolls + margin doesn't recover + tariff permanent — confirmed and quantified.

#### Source Index

| ID | Source |
|----|--------|
| S3 | NOV_financials/other/stockanalysis_summary.md |
| S5 | NOV_financials/sec_filings/10K_FY2025_summary.md |
| S6 | NOV_financials/other/consensus.md |
| S7 | NOV_financials/presentations/investor_presentation_2025.md |

## Full Research Available

This primer covers steps 1–3 of 19. The full deep dive (moat analysis, DCF, bull/bear,
management quality, earnings transcript analysis) is available via:

- Investment memo: /memo/nov
- Full research API: GET /api/v1/research/NOV/memo
- Coverage universe: /stocks